Pharma News

The most influential people in biopharma today

Any industry that's undergoing as much change as biopharma is always looking for leadership...
Learn more

BioMarin and its patient coaches are ready to roll on Vimizim launch

BioMarin Pharmaceuticals ($BMRN) nabbed the FDA's blessing for Vimizim, the only drug ever approved to treat a rare enzyme disorder called Morquio A syndrome. That's the good news...
Learn more

‘Intimate partnerships’: Parexel President shares CRO trends for 2014 10-Feb-2014

In an exclusive interview, Parexel’s president told Outsourcing-Pharma.com small pharma is increasing demand for CROs, commercialisation services are growing, and strategic partnerships are changing.
Learn more

Selecting Strategic Partners – The Lilly Way

As VP of Lilly Research Laboratories’ (LRL) operations and LRL Europe, Andy Dahlem puts his reputation on the line every day. When Eli Lilly and Company implemented its new outsourcing strategy several years ago, he was tasked with implementing it. The transformation took Lilly from a fully-integrated pharmaceutical company (FIPCO) to a fully-integrated pharmaceutical network (FIPNET) with numerous external partners.
Learn more


Leave a Reply